Cargando…
Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency
BACKGROUND: Since the first methodological publications on adaptive study design approaches in the 1990s, the application of these approaches in drug development has raised increasing interest among academia, industry and regulators. The European Medicines Agency (EMA) as well as the Food and Drug A...
Autores principales: | Elsäßer, Amelie, Regnstrom, Jan, Vetter, Thorsten, Koenig, Franz, Hemmings, Robert James, Greco, Martina, Papaluca-Amati, Marisa, Posch, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196072/ https://www.ncbi.nlm.nih.gov/pubmed/25278265 http://dx.doi.org/10.1186/1745-6215-15-383 |
Ejemplares similares
-
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency
por: Collignon, Olivier, et al.
Publicado: (2018) -
Evaluation of Companion Diagnostics in Scientific Advice and Drug Marketing Authorization Applications by the European Medicines Agency
por: Maliepaard, Marc, et al.
Publicado: (2022) -
The Use of Remote Monitoring Technologies: A Review of Recent Regulatory Scientific Advices, Qualification Opinions, and Qualification Advices Issued by the European Medicines Agency
por: Dekker, Marieke J. H. J., et al.
Publicado: (2021) -
Beyond this world: scientific missions of the European Space Agency
por: Calder, Nigel
Publicado: (1995) -
EMEA and Gene Therapy Medicinal Products Development in the European Union
por: Papaluca Amati, Marisa, et al.
Publicado: (2003)